Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 273784, 13 pages
http://dx.doi.org/10.1155/2015/273784
Research Article

Candesartan Mediated Amelioration of Cisplatin-Induced Testicular Damage Is Associated with Alterations in Expression Patterns of Nephrin and Podocin

Division of Urology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan

Received 14 May 2015; Accepted 30 July 2015

Academic Editor: Rafael Fissore

Copyright © 2015 Noritoshi Enatsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Schwarz, M. Simons, J. Reiser et al., “Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin,” Journal of Clinical Investigation, vol. 108, no. 11, pp. 1621–1629, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. T. B. Huber, B. Schermer, R. U. Müller et al., “Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17079–17086, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Y. Cheng and D. D. Mruk, “The blood-testis barrier and its implications for male contraception,” Pharmacological Reviews, vol. 64, no. 1, pp. 16–64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Chiba, K. Yamaguchi, M. Ando, H. Miyake, and M. Fujisawa, “Expression pattern of testicular claudin-11 in infertile men,” Urology, vol. 80, no. 5, pp. 1161.e13–1161.e17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Okada, H. Miyake, K. Yamaguchi et al., “Critical function of RA-GEF-2/Rapgef6, a guanine nucleotide exchange factor for Rap1, in mouse spermatogenesis,” Biochemical and Biophysical Research Communications, vol. 445, no. 1, pp. 89–94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Relle, H. Cash, C. Brochhausen et al., “New perspectives on the renal slit diaphragm protein podocin,” Modern Pathology, vol. 24, no. 8, pp. 1101–1110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Liu, K. Aya, H. Tanaka, J. Shimizu, S. Ito, and Y. Seino, “Nephrin is an important component of the barrier system in the testis,” Acta Medica Okayama, vol. 55, no. 3, pp. 161–165, 2001. View at Google Scholar · View at Scopus
  8. T. Nakatsue, H. Koike, G. D. Han et al., “Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy,” Kidney International, vol. 67, no. 6, pp. 2239–2253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Benigni, S. Tomasoni, E. Gagliardini et al., “Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis,” Journal of the American Society of Nephrology, vol. 12, no. 5, pp. 941–948, 2001. View at Google Scholar · View at Scopus
  10. S. Okui, H. Yamamoto, W. Li et al., “Cisplatin-induced acute renal failure in mice is mediated by chymase-activated angiotensin-aldosterone system and interleukin-18,” European Journal of Pharmacology, vol. 685, no. 1–3, pp. 149–155, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Saleh, A. A. Ain-Shoka, E. El-Demerdash, and M. M. Khalef, “Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury,” Chemotherapy, vol. 55, no. 6, pp. 399–406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Alves-Pereira, E. D. C. Frantz, and C. da Fonte Ramos, “Beneficial effects of renin-angiotensin system blockers on testicular steroidogenesis,” Journal of Urology, vol. 192, no. 6, pp. 1878–1883, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Kushwaha and G. B. Jena, “Effects of nicotine on the testicular toxicity of streptozotocin-induced diabetic rat: intervention of enalapril,” Human and Experimental Toxicology, vol. 33, no. 6, pp. 609–622, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Shiraishi, K.-I. Yoshida, T. Fujimiya, and K. Naito, “Angiotensin II dependent testicular fibrosis and effects on spermatogenesis after vasectomy in the rat,” Journal of Urology, vol. 170, no. 5, pp. 2104–2108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. P. M. Petersen, S. W. Hansen, A. Giwercman, M. Rorth, and N. E. Skakkebaek, “Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer,” Annals of Oncology, vol. 5, no. 4, pp. 355–358, 1994. View at Google Scholar · View at Scopus
  16. A. Giwercman and P. M. Petersen, “Cancer and male infertility,” Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 14, no. 3, pp. 453–471, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. L. M. Pogach, Y. Lee, S. Gould, W. Giglio, M. Meyenhofer, and H. F. S. Huang, “Characterization of cis-platinum-induced Sertoli cell dysfunction in rodents,” Toxicology and Applied Pharmacology, vol. 98, no. 2, pp. 350–361, 1989. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Mohammadnejad, A. Abedelahi, J. Soleimani-rad, A. Mohammadi-roshandeh, M. Rashtbar, and A. Azami, “Degenerative effect of cisplatin on testicular germinal epithelium,” Advanced Pharmaceutical Bulletin, vol. 2, no. 2, pp. 173–177, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals, “The national academies collection: reports funded by National Institutes of Health,” in Guide for the Care and Use of Laboratory Animals, National Academies Press, Ed., National Academy of Sciences, Washington, DC, USA, 2011. View at Google Scholar
  20. M. R. Ghassemifar, B. Sheth, T. Papenbrock, H. J. Leese, F. D. Houghton, and T. P. Fleming, “Occludin TM4-: an isoform of the tight junction protein present in primates lacking the fourth transmembrane domain,” Journal of Cell Science, vol. 115, no. 15, pp. 3171–3180, 2002. View at Google Scholar · View at Scopus
  21. A. Nambu and Y. Kumamoto, “Studies of spermatogenic damages induced by anti-cancer agent and anti-androgenic agents in rat testes,” The Japanese Journal of Urology, vol. 86, no. 7, pp. 1221–1230, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Kittikulsuth, J. S. Pollock, and D. M. Pollock, “Loss of renal medullary endothelin B receptor function during salt deprivation is regulated by angiotensin II,” The American Journal of Physiology—Renal Physiology, vol. 303, no. 5, pp. F659–F666, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Okada, M. Dobashi, T. Yamazaki et al., “Conventional versus microdissection testicular sperm extraction for nonobstructive azoospermia,” Journal of Urology, vol. 168, no. 3, pp. 1063–1067, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Verhoeven, E. Denolet, J. Swinnen et al., “The role of androgens in the control of spermatogenesis: lessons from transgenic models involving a Sertoli cell-selective knockout of the androgen receptor,” Animal Reproduction, vol. 4, no. 1-2, pp. 3–14, 2007. View at Google Scholar
  25. M. C. Leal, S. V. B. Pinheiro, A. J. Ferreira et al., “The role of angiotensin-(1–7) receptor Mas in spermatogenesis in mice and rats,” Journal of Anatomy, vol. 214, no. 5, pp. 736–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Schneeberger, P. Speiser, F. Kury, and R. Zeillinger, “Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain,” PCR Methods and Applications, vol. 4, no. 4, pp. 234–238, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Kawachi, H. Koike, H. Kurihara, T. Sakai, and F. Shimizu, “Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli,” Journal of the American Society of Nephrology, vol. 14, no. 1, pp. 46–56, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Fan, J. Ding, J. Zhang, N. Guan, and J. Deng, “Effect of the knockdown of podocin mRNA on nephrin and alpha-actinin in mouse podocyte,” Experimental Biology and Medicine, vol. 229, no. 9, pp. 964–970, 2004. View at Google Scholar · View at Scopus
  29. C. A. Schneider, W. S. Rasband, and K. W. Eliceiri, “NIH Image to ImageJ: 25 years of image analysis,” Nature Methods, vol. 9, no. 7, pp. 671–675, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Sato, K. Seyama, Y. Sato et al., “Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 5, pp. 530–537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. B. I. Frohnert and D. A. Bernlohr, “Protein carbonylation, mitochondrial dysfunction, and insulin resistance,” Advances in Nutrition, vol. 4, no. 2, pp. 157–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. H.-H. Parving, H. Lehnert, J. Brochner-Mortensen, R. Gomis, S. Andersen, and P. Arner, “The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 345, no. 12, pp. 870–878, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Lin, W. Ye, L. Cai et al., “The roles of multiple importins for nuclear import of murine aristaless-related homeobox protein,” The Journal of Biological Chemistry, vol. 284, no. 30, pp. 20428–20439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Schnabel, J. M. Anderson, and M. G. Farquhar, “The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium,” Journal of Cell Biology, vol. 111, no. 3, pp. 1255–1263, 1990. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Kawachi, N. Miyauchi, K. Suzuki, D. H. Gi, M. Orikasa, and F. Shimizu, “Role of podocyte slit diaphragm as a filtration barrier,” Nephrology, vol. 11, no. 4, pp. 274–281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. L. M. Domke, S. Rickelt, Y. Dörflinger et al., “The cell-cell junctions of mammalian testes: I. The adhering junctions of the seminiferous epithelium represent special differentiation structures,” Cell and Tissue Research, vol. 357, no. 3, pp. 645–665, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Gotoh, M. Mine, K. Ishizaka, H. Kaneoya, and M. Yokokawa, “Changes in lanthanum permeability of rat Sertoli cell tight junction after CDDP administration,” The Japanese Journal of Urology, vol. 81, no. 1, pp. 45–48, 1990. View at Google Scholar
  38. F. Bonnet, M. E. Cooper, H. Kawachi, T. J. Allen, G. Boner, and Z. Cao, “Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension,” Diabetologia, vol. 44, no. 7, pp. 874–877, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. T. B. Huber, M. Köttgen, B. Schilling, G. Walz, and T. Benzing, “Interaction with podocin facilitates nephrin signaling,” Journal of Biological Chemistry, vol. 276, no. 45, pp. 41543–41546, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. B. S. Brooke, J. P. Habashi, D. P. Judge, N. Patel, B. Loeys, and H. C. Dietz III, “Angiotensin II blockade and aortic-root dilation in Marfan's syndrome,” The New England Journal of Medicine, vol. 358, no. 26, pp. 2787–2795, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Fuchs, K. Frenzel, C. Hubert et al., “Male fertility is dependent on dipeptidase activity of testis ACE,” Nature Medicine, vol. 11, no. 11, pp. 1140–1142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Ichiki, “Angiotensin II accelerates vascular inflammation and atherosclerosis,” The Journal of Japanese College of Angiology, vol. 49, no. 4, pp. 287–292, 2009. View at Google Scholar
  43. K. K. Griendling, C. A. Minieri, J. D. Ollerenshaw, and R. W. Alexander, “Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells,” Circulation Research, vol. 74, no. 6, pp. 1141–1148, 1994. View at Publisher · View at Google Scholar · View at Scopus
  44. R. John Aitken and S. D. Roman, “Antioxidant systems and oxidative stress in the testes,” Advances in Experimental Medicine and Biology, vol. 636, pp. 153–171, 2008. View at Google Scholar · View at Scopus
  45. N. Kilarkaje, A. M. Mousa, M. M. Al-Bader, and K. M. Khan, “Antioxidants enhance the recovery of three cycles of bleomycin, etoposide, and cisplatin-induced testicular dysfunction, pituitary-testicular axis, and fertility in rats,” Fertility and Sterility, vol. 100, no. 4, pp. 1151.e5–1159.e5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Anand, M. M. Misro, S. B. Sharma, and S. Prakash, “Protective effects of Eugenia jambolana extract versus N-acetyl cysteine against cisplatin-induced damage in rat testis,” Andrologia, vol. 47, no. 2, pp. 194–208, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Narayana, M. Al-Bader, A. Mousa, and K. M. Khan, “Molecular effects of chemotherapeutic drugs and their modulation by antioxidants in the testis,” European Journal of Pharmacology, vol. 674, no. 2-3, pp. 207–216, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. E. A. Salem, N. A. Salem, A. M. Maarouf, E. C. Serefoglu, and W. J. G. Hellstrom, “Selenium and lycopene attenuate cisplatin-induced testicular toxicity associated with oxidative stress in Wistar rats,” Urology, vol. 79, no. 5, pp. 1184.e1–1184.e6, 2012. View at Publisher · View at Google Scholar · View at Scopus